Feedback / Questions
KAN-001 - Kanvas Biosci
KAN-003 - Kanvas Biosci
https://www.prnewswire.com/news-releases/kanvas-biosciences-secures-additional-12-5m-to-advance-its-novel-microbiome-based-immuno-oncology-drug-candidates-to-ind-filing-302184016.html
 
Jul 1, 2024
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious